KP372-1-induced DNA Damage as a Chemotherapeutic Approach to Treat Cancer
Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION, Socorro, New Mexico has been assigned a patent (No. US 12128050 B2, initially filed Nov. 10, 2021) developed by Praveen Patidar, Socorro, New Mexico, and Talysa Viera, Socorro, New Mexico, for "KP372-1-induced DNA damage as a chemotherapeutic approach to treat cancer." . . .